Ling Li
Impact in
- Cancer Research top 0.2%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Neurology top 0.5%
- Neuroinflammation and Neurodegeneration Mechanisms
Papers in
-
- MicroRNA in disease regulation 20
- Co-authors
- Chang‐Zheng ChenHarvey F. LodishDavid P. BartelLiqun LuoBosiljka TasicKazunari MiyamichiMandar D. MuzumdarRobert Desimone
- Journals
- Journal of Biological Chemistry (6 papers)Biochemistry (6 papers)Proceedings of the National Academy of Sciences (5 papers)Molecular Neurobiology (5 papers)European Journal of Medicinal Chemistry (5 papers)
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Ling Li
492 papers receiving 20.3k citations
Hit Papers
Peers
Comparison fields: 5 of 199
- Cancer Research 3.4k
- Neurology 1.3k
- Molecular Biology 10.2k
- Biological Psychiatry 370
- Aging 252
Countries citing papers authored by Ling Li
This map shows the geographic impact of Ling Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ling Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ling Li more than expected).
Fields of papers citing papers by Ling Li
This network shows the impact of papers produced by Ling Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ling Li. The network helps show where Ling Li may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ling Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 5 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 3 | |
| 6 | 2024 | 25 | |
| 7 | 2024 | 37 | |
| 8 | 2024 | 5 | |
| 9 | 2023 | 39 | |
| 10 | 2023 | 4 | |
| 11 | 2023 | 20 | |
| 12 | 2023 | 14 | |
| 13 | 2023 | 25 | |
| 14 | 2023 | 1 | |
| 15 | 2020 | 1 | |
| 16 | Silencing of c-jun decreases cell migration, invasion, and EMT in radioresistant human nasopharyngeal carcinoma cell line CNE-2R | 2018 | 2 |
| 17 | 2013 | 1 | |
| 18 | 2011 | 24 | |
| 19 | Cultured human embryonic neocortical cells survive and grow in infarcted cavities of adult rat brains and interconnect with host brain. | 2005 | 2 |
| 20 | MicroRNAs Modulate Hematopoietic Lineage Differentiation Hit paper breakdown → | 2003 | 2706 |
About Ling Li
Ling Li is a scholar working on Biological Psychiatry, Cancer Research, Molecular Biology, Neurology and Physiology, having authored 519 papers that have together received 20.7k indexed citations. Recurring topics across this work include Alzheimer's disease research and treatments (49 papers), Cholesterol and Lipid Metabolism (21 papers), MicroRNA in disease regulation (20 papers), RNA Interference and Gene Delivery (20 papers), Neuroinflammation and Neurodegeneration Mechanisms (19 papers), Peroxisome Proliferator-Activated Receptors (15 papers), Computational Drug Discovery Methods (14 papers) and CRISPR and Genetic Engineering (13 papers). The work is most often cited by research in Cancer Research (3.4k citations), Neurology (1.3k citations), Molecular Biology (10.2k citations), Biological Psychiatry (370 citations) and Aging (252 citations). Ling Li has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Chang‐Zheng Chen, Harvey F. Lodish, David P. Bartel, Liqun Luo, Bosiljka Tasic, Kazunari Miyamichi, Mandar D. Muzumdar, Robert Desimone, Earl K. Miller and Dongfeng Cao. Their work appears in journals such as Journal of Biological Chemistry, Biochemistry, Proceedings of the National Academy of Sciences, Molecular Neurobiology and European Journal of Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.